Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities
Harmine 1 was extracted from the seeds of Peganum harmala. From this natural molecule, a new series of isoxazole derivatives with complete regiospecificity were prepared using 1,3-dipolar cycloaddition reactions with various arylnitrile oxides. Harmine and its derivatives were characterized by (1)H NMR, (13)C NMR and HRMS. The evaluation of their anti-acetylcholinesterase (AChE), anti-5-lipoxygenase (5-LOX), anti-xanthine oxidase (XOD) and anticancer activities were studied in vitro against AChE, 5-LOX and XOD enzymes, respectively, and in HTC-116, MCF7 and OVCAR-3 cancer cell lines. The prepared derivatives were shown to be inactive against the XOD enzyme (0-38.3 ± 1.9% at 100 µM). Compound 2 exhibited the best anti-AChE activity (IC50=1.9 ± 1.5 µM). Derivatives 3a, 3b and 3d had moderate cytotoxic activities (IC50=5.0 ± 0.3 µM (3a) and IC50=6.3 ± 0.4 µM (3b) against HCT 116 cells, IC50=5.0 ± 1.0 µM (3d) against MCF7 cells).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Medicinal chemistry (Shariqah (United Arab Emirates)) - 12(2016), 2 vom: 10., Seite 184-90 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Filali, Insaf [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 02.03.2017 Date Revised 27.10.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM252683838 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM252683838 | ||
003 | DE-627 | ||
005 | 20231224164627.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0842.xml |
035 | |a (DE-627)NLM252683838 | ||
035 | |a (NLM)26362768 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Filali, Insaf |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.03.2017 | ||
500 | |a Date Revised 27.10.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Harmine 1 was extracted from the seeds of Peganum harmala. From this natural molecule, a new series of isoxazole derivatives with complete regiospecificity were prepared using 1,3-dipolar cycloaddition reactions with various arylnitrile oxides. Harmine and its derivatives were characterized by (1)H NMR, (13)C NMR and HRMS. The evaluation of their anti-acetylcholinesterase (AChE), anti-5-lipoxygenase (5-LOX), anti-xanthine oxidase (XOD) and anticancer activities were studied in vitro against AChE, 5-LOX and XOD enzymes, respectively, and in HTC-116, MCF7 and OVCAR-3 cancer cell lines. The prepared derivatives were shown to be inactive against the XOD enzyme (0-38.3 ± 1.9% at 100 µM). Compound 2 exhibited the best anti-AChE activity (IC50=1.9 ± 1.5 µM). Derivatives 3a, 3b and 3d had moderate cytotoxic activities (IC50=5.0 ± 0.3 µM (3a) and IC50=6.3 ± 0.4 µM (3b) against HCT 116 cells, IC50=5.0 ± 1.0 µM (3d) against MCF7 cells) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Cholinesterase Inhibitors |2 NLM | |
650 | 7 | |a Isoxazoles |2 NLM | |
650 | 7 | |a Lipoxygenase Inhibitors |2 NLM | |
650 | 7 | |a Tamoxifen |2 NLM | |
650 | 7 | |a 094ZI81Y45 |2 NLM | |
650 | 7 | |a Harmine |2 NLM | |
650 | 7 | |a 4FHH5G48T7 |2 NLM | |
650 | 7 | |a Xanthine Oxidase |2 NLM | |
650 | 7 | |a EC 1.17.3.2 |2 NLM | |
700 | 1 | |a Romdhane, Anis |e verfasserin |4 aut | |
700 | 1 | |a Znati, Mansour |e verfasserin |4 aut | |
700 | 1 | |a Jannet, Hichem B |e verfasserin |4 aut | |
700 | 1 | |a Bouajila, Jalloul |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicinal chemistry (Shariqah (United Arab Emirates)) |d 2005 |g 12(2016), 2 vom: 10., Seite 184-90 |w (DE-627)NLM163628467 |x 1875-6638 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2016 |g number:2 |g day:10 |g pages:184-90 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2016 |e 2 |b 10 |h 184-90 |